Alembic Pharmaceuticals Ltd.
| BSE: 533573 | Sector: Health care |
| NSE: APLLTD | ISIN Code: INE901L01018 |
| BSE 00:00 | 09 Feb | 521.60 |
-4.90 (-0.93%) |
OPEN
521.15 |
HIGH
530.35 |
LOW
521.00 |
| NSE 00:00 | 09 Feb | 521.60 |
-5.30 (-1.01%) |
OPEN
526.10 |
HIGH
530.90 |
LOW
521.00 |
| OPEN | 521.15 |
| PREVIOUS CLOSE | 526.50 |
| VOLUME | 1332 |
| 52-Week high | 792.30 |
| 52-Week low | 518.10 |
| P/E | 21.93 |
| Mkt Cap.(Rs cr) | 10,252 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Alembic Pharmaceuticals Ltd. (APLLTD) - Latest News & Headlines
-
Stocks to Watch: NTPC, LIC Housing, Alembic Pharma, SIS, Gail, Puravankara
8.03 am | 27 Dec 2022 | Business Standard
Stocks to Watch: In the F&O space, Punjab National Bank (PNB) is the only stock in ban period on Tuesday.
-
Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
5.30 pm | 26 Dec 2022 | Press Trust of India
Alembic Pharmaceuticals on Monday said it has received final approval from the US health regulator for its generic Fulvestrant injection used in treat...
Quick Links for Alembic Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
